Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Sanofi seeks to prevent Praluent injunction
Americas
Sanofi and Regeneron have filed the latest round of their appeal to the US Court of Appeals for the Federal Circuit in a bid to stop an injunction against Praluent.   9 May 2017
Generic companies ask district court to dismiss Takeda competition claims
Americas
Four generic companies have pushed a district court to dismiss competition allegations against them, stating that the latest amendments made by American Sales Company in a class action complaint are “purely cosmetic” and add no new factual allegations.   9 May 2017
Americas
Michael Best & Friedrich has strengthened its IP team with the addition of Mircea Tipescu as a partner in the firm’s IP practice in Chicago.   9 May 2017
Americas
Baxalta, a wholly-owned subsidiary of Shire, has filed a patent infringement complaint against Genentech and Chugai Pharmaceutical.   8 May 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed and remanded a ruling by a district court in a patent dispute between pharmaceutical company Braintree Laboratories and Breckenridge Pharmaceutical.   8 May 2017
article
The English High Court has concluded that a supplementary protection certificate challenged by Sandoz is valid, dismissing the dispute.   5 May 2017
Africa
The World Health Organization will launch a pilot project for biosimilars to make costly cancer treatments more widely available in low and middle income countries.   5 May 2017
Americas
The US Patent and Trademark Office won a case against biotech company NantKwest yesterday at the US Court of Appeals for the Federal Circuit.   4 May 2017
Americas
AstraZeneca has entered into a collaboration with biotech company Pieris Pharmaceuticals to develop novel inhaled drugs that expand on Pieris’s Anticalin platform.   4 May 2017
Americas
A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly.   3 May 2017